COMPASS Pathways Plc American Depository Shares
Market Cap
1.8B
Short interest (May 15)
5.7%
Borrow Fee
0.41%
↓ 1.5%
Available Shares
6M
↑ 1.3%
Price Chart
Company Overview
Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.
Company Info
Market Data
Short Interest
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.